Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases
- 30 April 2003
- journal article
- Published by Elsevier in Seminars in Hematology
- Vol. 40 (2) , 116-123
- https://doi.org/10.1016/s0037-1963(03)70003-1
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Epitope-specific Evolution of Human CD8+ T Cell Responses from Primary to Persistent Phases of Epstein-Barr Virus InfectionThe Journal of Experimental Medicine, 2002
- Epstein–Barr Virus InfectionNew England Journal of Medicine, 2000
- PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1Transplantation, 1998
- Acyclovir and Prednisolone Treatment of Acute Infectious Mononucleosis: A Multicenter, Double-Blind, Placebo-Controlled StudyThe Journal of Infectious Diseases, 1996
- Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells.Journal of Clinical Investigation, 1994
- Risk of agranulocytosis and aplastic anemia in relation to history of infectious mononucleosis: A report from the international agranulocytosis and aplastic anemia studyAnnals of Hematology, 1993
- Epstein-Barr Virus Lymphoproliferative Disease Associated with Acquired ImmunodeficiencyMedicine, 1991
- Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious MononucleosisNew England Journal of Medicine, 1979
- T- and B-Cells in Peripheral Blood during Infectious MononucleosisThe Journal of Infectious Diseases, 1974
- VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Lancet, 1964